Plus Therapeutics (PSTV) Dividends Paid - Common (2015)
Plus Therapeutics (PSTV) reported Dividends Paid - Common of $3000.0 for Q2 2015, down 95.83% quarter-over-quarter from $72000.0 in Q1 2015.
Plus Therapeutics (PSTV) Dividends Paid - Common (2015) Analysis & Trends
Plus Therapeutics (PSTV) has 1 years of Dividends Paid - Common data on file, last reported at $3000.0 in Q2 2015.
- Dividends Paid - Common for Q2 2015 came in at $3000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2016 was $3000.0 (down 95.83% YoY), and the FY2015 annual result was $75000.0, changed N/A from the prior year.
- Dividends Paid - Common fell to $3000.0 in Q2 2015 per PSTV's latest filing, from $72000.0 in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $72000.0 in Q1 2015 and troughed at $3000.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 3,000.00 |
| Jun 30, 2015 | 3,000.00 |
| Mar 31, 2015 | 72,000.00 |
| Mar 31, 2015 | 72,000.00 |